Raydiant Oximetry Launches IDE Pilot Study at LSU Health Shreveport to Advance Fetal Monitoring Technology
SAN RAMON, CA, November 5, 2025 — Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering innovations in fetal monitoring through advanced biophotonics and machine learning, today announced the initiation of an Investigational Device Exemption (IDE) Pilot Study at Louisiana State University Health Shreveport (LSUHS).
Raydiant Oximetry Successfully Completes 35-Patient Early Feasibility Study at Eastern Virginia Medical School at Old Dominion University
SAN RAMON, Calif., October 16, 2025 — Raydiant Oximetry, Inc., a clinical-stage medical device company pioneering fetal monitoring innovations through advanced biophotonics and machine learning, today announced the successful completion of a 35-patient Early Feasibility Study (EFS) at Macon & Joan Brock Virginia Health Sciences Eastern Virginia Medical School (EVMS) at Old Dominion University.